Alberto Borobia Pérez-rekin lankidetzan egindako argitalpenak (3)

2023

  1. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units

    Clinical and Translational Science, Vol. 16, Núm. 12, pp. 2421-2428

2022

  1. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130